2Koh SC, Prasad RN, Fong YF. Hemostatic status and fibrinolytic re- sponse potential at different phases of the menstrual cycle [ J ]. Clin Appl Thromb Hemost ,2005,11 (3) :295-301.
3Sheikh SA, Roshan TM, Khattak MN, et al. Short-term estrogen re- placement therapy reduces platelet marker levels in Malaysian post- menpausal women[ J]. Menopause Int,2011,17( 1 ) :6-10.
4Nachtigall MJ ,Jessel RH, Flaumenhaft R, et al. The selective estrogen receptor modulator DT56a does not affect platelet reactivity in normal or thrombophilic postmenopausal women [ J ]. Menopause, 2011,82 (5) :825-836.
5Bonduki CE, Lourenco DM, Motta EL, et al. Effect of estrogen-proges- tin hormonal replacement therapy on blood coagulation and fibrinolysis in postmenopausal women [ J ]. Clinics,2007,62 ( 5 ) :53-56.
6Keramaris NC, Christodoulakos GE, Lambrinoudaki IV, et al. The dif- ferential effect of estrogen, estrogen-progestin and tibolone on coagula- tion inhibitors in postmenopausal women [ J ]. Climacteric, 2007,10 (5) :400-407.
